Linking Malaysia

Berita Malaysia, Orang, Cerita Perniagaan

Menu
  • Home
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • Berita
  • Perniagaan
  • kewangan
  • Contact
Menu

Custics Announces the Release of ‘Hautuki’, a Peptide Patch for Height Growth

Posted on Mac 10, 2024 by min

Utilizing Patented Technology from Seoul National University’s Department of Biotechnology

Seoul, Korea – 10/03/2024 – (SeaPRwire) – The South Korean company Custics has launched Hautuki (Chinese name 好大技), a height growth supplement that incorporates patented peptide technology from the Department of Biotechnology at Seoul National University, and it is now available for sale on Shopee.

A representative from Custics stated, “The peptide technology promotes the delivery of nutrients into the body through the pores. The transdermal delivery method allows for the absorption of nutrients without the burdens associated with oral administration.”

The Transdermal Drug Delivery System (TDDS) is a drug delivery method that has been receiving attention recently. It offers several advantages, including localized application, bypassing first-pass metabolism through the liver, sustained release of the drug, and patient convenience.

Although similar patented technologies have existed, none have described the transdermal delivery of drugs through pores using peptides as applied in Hautuki.

Moreover, Hautuki is enriched with nutrients essential for height growth, including highly absorbable Vitamin D3, along with Calcium, Vitamin K1 (which assists in the synthesis of Vitamin D3), and Magnesium. Vitamin K1 helps prevent the loss of Calcium, and Magnesium increases the absorption and metabolic rate of Calcium when taken together.

Hautuki is especially appreciated for its ease of use by both parents and children. It can be applied before bedtime to areas of the skin that are not thick, such as the back of the hand, knees, and top of the feet.

Furthermore, “Hautuki is registered as an OTC drug with the U.S. FDA and has completed skin irritation tests, making it a safe product that is also sold in Korean pharmacies,” added the spokesperson.

This product is designed for children and adolescents during their growth phases and is recommended to be used once a day, for more than four hours at a time.

Media Contact

Brand: CUSTICS / Hautuki

Contact: Marketing Team

Website: https://hautuki.co.kr

SOURCE: CUSTICS / Hautuki

The article is provided by a third-party content provider. SeaPRwire ( https://www.seaprwire.com/ ) makes no warranties or representations in connection therewith.

Sectors: Top Story, Corporate News

SeaPRwire provides real time press release distribution for companies and organizations to 6,500+ media outlets & 3.5 million professional desktops in 90 regions. It distributes press releases in different languages, including: IndonesiaFolk, IndoNewswire, SEATribune, IDNewsZone, LiveBerita, DailyBerita, TaiwanPR, SinchewBusiness, AsiaEase, BuzzHongKong, SingapuraNow, TIHongKong, TaipeiCool, TWZip, AsiaFeatured, dePresseNow, THNewson, KULPR, VNFeatured, MENAEntry, HunaTimes, DubaiLite, ArabicDir, BeritaDaring, TekanAsia, JamKopi ...

Navigasi

  • Muka depan
  • SeaPRwire
  • ACN Newswire
  • JCN Newswire
  • Berita
  • Perniagaan
  • kewangan
  • About
  • Contact

Kiriman Terkini

  • Tsuburaya Productions Memperkenalkan Era Baru Penjahat Dengan “Shadow of Undying Vengeance” – Booster Pek Bertemakan Kaiju Pertama Dalam Permainan Kad Ultraman
  • KAIGE Global Financial Leading the Future of Wealth with Risk Assessment Global Supervision International Organizations and Certification Excellence
  • Nissin Foods Announces 2025 Q1 Financial Results
  • GA Skylight Berhad c/o Skylight Group Announces Prospective Strategic Investment from Instrak Venture Capital Berhadx
  • Adyen and JCB launch Card-on-File Tokenization to Enhance Payment Security

Links

  • YAHOO
  • NASDAQ
  • Bloomberg
  • Newswire
  • EastMud
  • AsiaEase
  • NetDace
  • PostVN
  • VOASG
  • EventPH
Copyright © 2020 Linkingmy.Com. All right reserved.